Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam tosylate versus propofol for hysteroscopic surgery under BIS monitoring
ChiCTR2200066744Phase 4Not yet recruiting
- Sponsor
- Department of Anesthesiology, Renmin Hospital of Wuhan University
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam and propofol in None (2 arms), sponsored by Department of Anesthesiology, Renmin Hospital of Wuhan University. Primary endpoints: Heart rate, Mean arterial pressure and 2 more. Planned start Dec 2022; status: not yet recruiting.
02
Drugs
remimazolampropofol
Beyond the preview
Go deeper on ChiCTR2200066744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200066744.